These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2507719)

  • 1. [Postprandial hypotension.syncope in Shy-Drager syndrome and its treatment with oral L-DOPS].
    Hasegawa Y; Koike Y; Matsuoka Y; Takahashi A
    Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):939-43. PubMed ID: 2507719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
    Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
    Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
    Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperthermia in a Shy-Drager syndrome patient--pathophysiological effects of body temperature and L-DOPS on orthostatic hypotension].
    Yamamoto K; Morita S; Ikeda S; Yanagisawa N
    Rinsho Shinkeigaku; 1993 Jan; 33(1):68-73. PubMed ID: 8334778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylsalicylic acid and indomethacin in the treatment of idiopathic orthostatic hypotension and Shy-Drager's syndrome].
    Hinge HH; Mikkelsen B; Korsager S
    Ugeskr Laeger; 1985 Apr; 147(14):1196-8. PubMed ID: 4002380
    [No Abstract]   [Full Text] [Related]  

  • 6. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
    Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin and propranolol combined treatment for Shy-Drager syndrome.
    Galassi G
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):472-3. PubMed ID: 7086460
    [No Abstract]   [Full Text] [Related]  

  • 8. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
    Schirger A; Sheps SG; Thomas JE; Fealey RD
    Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease.
    Gupta F; Kremens D; Vernino S; Karabin B
    Clin Auton Res; 2017 Jul; 27(Suppl 1):9-11. PubMed ID: 28699048
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome.
    Rae-Grant A; Young GB; Spence JD
    Neurology; 1985 Jul; 35(7):1085-6. PubMed ID: 4010957
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Fagard R; Knockaert D
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome).
    West JN; Stallard TJ; Dimmitt SB; Smith SA; Williams A; Littler WA
    Q J Med; 1990 Feb; 74(274):209-13. PubMed ID: 1971724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of orthostatic hypotension by propranolol in the Shy-Drager syndrome.
    Brevetti G; Chiariello M; Giudice P; De Michele G; Mansi D; Campanella G
    Am Heart J; 1981 Nov; 102(5):938-41. PubMed ID: 7304404
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of "pure" progressive autonomic failure in an elderly male].
    Kuwahara T; Okura T; Matsumoto S; Dazai Y; Iwata T; Hiwada K
    Nihon Ronen Igakkai Zasshi; 1992 Oct; 29(10):790-3. PubMed ID: 1460785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic orthostatic hypotension (Shy-Drager syndrome). Clinical and hemodynamic studies of a case].
    Russo R; Permutti B; Crociani P; Bortolotti U; Fernandez P; Schivazappa L
    Minerva Med; 1981 Oct; 72(39):2621-4. PubMed ID: 7290466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shy-Drager syndrome. Description of a case].
    Gómez Huelgas R; Cobo Reinoso ME; Quirós Doñate J; Marín Hernández G
    Rev Clin Esp; 1985 Feb; 176(2):91-3. PubMed ID: 3991953
    [No Abstract]   [Full Text] [Related]  

  • 17. Shy-Drager syndrome. Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow.
    Matsubara S; Sawa Y; Yokoji H; Takamori M
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):994-7. PubMed ID: 2283531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic orthostatic hypotension (Shy Drager's syndrome) (author's transl)].
    Idiáquez J
    Rev Med Chil; 1980 Nov; 108(11):1024-7. PubMed ID: 7244448
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and treatment of Shy-Drager syndrome].
    Gubskiĭ LV
    Sov Med; 1989; (6):115-7. PubMed ID: 2799483
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
    Kachi T; Iwase S; Mano T; Saito M; Kunimoto M; Sobue I
    Neurology; 1988 Jul; 38(7):1091-4. PubMed ID: 3133573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.